FR2042290A1 - Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders - Google Patents
Compositions containing uridine 5 diphospho- - glucose for treatment of liver disordersInfo
- Publication number
- FR2042290A1 FR2042290A1 FR6912973A FR6912973A FR2042290A1 FR 2042290 A1 FR2042290 A1 FR 2042290A1 FR 6912973 A FR6912973 A FR 6912973A FR 6912973 A FR6912973 A FR 6912973A FR 2042290 A1 FR2042290 A1 FR 2042290A1
- Authority
- FR
- France
- Prior art keywords
- treatment
- diphospho
- glucose
- liver disorders
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Abstract
Comps. contg. uridine-51-diphosphoglucose (I) are useful in the treatment of liver disorders such as hepatitis, jaundice, and cirrhosis : In an example, 20 mg. (I) as its disodium salt and 150 mg. aminoacetic acid were lyophilised and sealed in an ampoule. The powder was dissolved in 3 ml. distilled water for injection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR6912973A FR2042290A1 (en) | 1969-04-24 | 1969-04-24 | Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR6912973A FR2042290A1 (en) | 1969-04-24 | 1969-04-24 | Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2042290A1 true FR2042290A1 (en) | 1971-02-12 |
Family
ID=9032995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR6912973A Withdrawn FR2042290A1 (en) | 1969-04-24 | 1969-04-24 | Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2042290A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2452467A1 (en) * | 1973-11-08 | 1975-05-15 | Yamasa Shoyu Kk | CRYSTALLINE SODIUM SALT OF URIDINE 5'-DIPHOSPHATE-GLUCOSE AND THE PROCESS FOR ITS PRODUCTION |
WO1991000867A1 (en) * | 1989-07-10 | 1991-01-24 | University Of Georgia Research Foundation, Inc. | 5'-diphosphohexose nucleoside pharmaceutical compositions |
US5118672A (en) * | 1989-07-10 | 1992-06-02 | University Of Georgia Research Foundation | 5'-diphosphohexose nucleoside pharmaceutical compositions |
-
1969
- 1969-04-24 FR FR6912973A patent/FR2042290A1/en not_active Withdrawn
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2452467A1 (en) * | 1973-11-08 | 1975-05-15 | Yamasa Shoyu Kk | CRYSTALLINE SODIUM SALT OF URIDINE 5'-DIPHOSPHATE-GLUCOSE AND THE PROCESS FOR ITS PRODUCTION |
US5159067A (en) * | 1987-01-28 | 1992-10-27 | University Of Georgia Research Foundation Inc. | 5'-Diphosphohexose nucleoside pharmaceutical compositions |
WO1991000867A1 (en) * | 1989-07-10 | 1991-01-24 | University Of Georgia Research Foundation, Inc. | 5'-diphosphohexose nucleoside pharmaceutical compositions |
US5118672A (en) * | 1989-07-10 | 1992-06-02 | University Of Georgia Research Foundation | 5'-diphosphohexose nucleoside pharmaceutical compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS54147916A (en) | Preparation of urokinase injection | |
ES438931A1 (en) | Compositions for treatment of cardiovascular conditions associated with overproduction of catecholamines | |
FR2042290A1 (en) | Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders | |
GB1297080A (en) | ||
BE773903A (en) | PROCESS FOR PREPARING AN ENZYMATIC COMPOSITION IN PARTICULAR FORM | |
ES415226A1 (en) | Method of enhancing vincamine compositions | |
FR2441387A1 (en) | CEPHRADINE COMPOSITIONS AND PROCESSES FOR THEIR PREPARATION | |
GB1261147A (en) | Pentanedione derivatives | |
DE3165050D1 (en) | Salt of furosemide or piretanide as acid component and penbutolol as base component and pharmaceutical composition containing both of the said components | |
GB1224605A (en) | Method for preventing colouring of vitamin c | |
GB1301555A (en) | ||
FR2081364A1 (en) | Compsn for oral calcitherapy | |
FR2123632A6 (en) | Prepn of 5-azacytosines and 5-azacytidines - from bis trimethylsilyl-5-azacytosine | |
GB1093382A (en) | Improvements in dummy combat substances | |
GB1254652A (en) | C20-aminodicarboxylic acids and derivatives thereof | |
BE755067A (en) | AQUEOUS POLYMERISATE DISPERSIONS, CONTAINING P-AMINOBENZOIC ACID DERIVATIVES | |
GB1176157A (en) | Orotic Acid Salt | |
IL34404A0 (en) | Insecticidal compositions containing 2-chloro-2-thiono-1,3,2-dioxaphosphorinane derivatives and certain new compounds of this type | |
JPS5170769A (en) | 10*111 jihidoro 33 karubokishishipuroheputajin oyobi sono nn okisaido | |
GB1290593A (en) | ||
GB909365A (en) | Orally ingestible solid penicillin compositions | |
IL35541A0 (en) | Preparation of(-)(cis-1,2,-epoxypropyl phosphonic acid | |
GB959819A (en) | Improvements in or relating to podophyllinic acid ethyl hydrazide | |
GB1298623A (en) | Benzocyclohepta-oxazole and -thiazole derivatives | |
ES458413A1 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |